-
Signature
-
/s/ W. Eric Marr, as Attorney-In-Fact for Christine M. Martin
-
Stock symbol
-
PPL
-
Transactions as of
-
May 23, 2025
-
Transactions value $
-
-$95
-
Form type
-
4
-
Date filed
-
5/28/2025, 04:39 PM
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Martin Christine M |
President of a PPL Subsidiary |
645 HAMILTON STREET, ALLENTOWN |
/s/ W. Eric Marr, as Attorney-In-Fact for Christine M. Martin |
2025-05-28 |
0002005520 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
PPL |
Common Stock |
Options Exercise |
$14.9K |
+429 |
+1.18% |
$34.67 |
36.9K |
May 23, 2025 |
Direct |
F1 |
| transaction |
PPL |
Common Stock |
Tax liability |
-$4.26K |
-123 |
-0.33% |
$34.67 |
36.7K |
May 23, 2025 |
Direct |
F1, F2 |
| transaction |
PPL |
Common Stock |
Sale |
-$10.7K |
-306 |
-0.83% |
$34.98 |
36.4K |
May 27, 2025 |
Direct |
F1, F3 |
| holding |
PPL |
Common Stock |
|
|
|
|
|
239 |
May 23, 2025 |
Held in trust pursuant to the Employee Stock Ownership Plan. |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
PPL |
Stock Unit (ICPKE) |
Options Exercise |
$0 |
-429 |
-100% |
$0.00 |
0 |
May 23, 2025 |
Common Stock |
429 |
$0.00 |
Direct |
F4 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: